Bank of New York Mellon’s Allied Healthcare Products AHPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,946
Closed -$10K 4327
2016
Q3
$10K Sell
5,946
-988
-14% -$1.2K ﹤0.01% 4249
2016
Q2
$8K Hold
6,934
﹤0.01% 4301
2016
Q1
$10K Hold
6,934
﹤0.01% 4196
2015
Q4
$16K Hold
6,934
﹤0.01% 4292
2015
Q3
$16K Hold
6,934
﹤0.01% 4332
2015
Q2
$22K Sell
6,934
-283
-4% -$862 ﹤0.01% 4218
2015
Q1
$24K Hold
7,217
﹤0.01% 4189
2014
Q4
$27K Hold
7,217
﹤0.01% 4197
2014
Q3
$29K Hold
7,217
﹤0.01% 4182
2014
Q2
$35K Hold
7,217
﹤0.01% 4102
2014
Q1
$33K Hold
7,217
﹤0.01% 4122
2013
Q4
$33K Hold
7,217
﹤0.01% 4145
2013
Q3
$33K Hold
7,217
﹤0.01% 4090
2013
Q2
$40K Buy
+7,217
New +$38.5K ﹤0.01% 4062

Other funds holding AHPI

Bank of New York Mellon's AHPI Position: Q4 2016 in Review

Bank of New York Mellon sold out of Allied Healthcare Products (AHPI) in Q4 2016, closing a stake of 5,946 shares — an estimated $10K sold.

Bank of New York Mellon first reported a position in AHPI in Q2 2013 and held it in 14 quarters. The position peaked at $40K in Q2 2013. 10 funds tracked by Wall St. Rank hold AHPI as of Q4 2016.

  • Bank of New York Mellon reported no remaining Allied Healthcare Products position as of Q4 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 5,946 Allied Healthcare Products shares in Q4 2016, an estimated $10K.
  • Bank of New York Mellon first reported a position in Allied Healthcare Products in Q2 2013 and held it in 14 quarters.
  • Bank of New York Mellon's Allied Healthcare Products position peaked at $40K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q4 2016.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.